Pre-classification issue
About This Event
Do you have those troubles & risks?
- Pre-classification issue
Base on the H.S. code, some biopharmaceutical products are involved CCC, and the 3C application need a lot of documention and a very long time which cannot meet the time requirements of CRO’s clinical trial.
- Timeliness and expiration issue
A repetitious levy based on the value of the biopharmaceutical products happens when exchange repeat between oversea and domestic customers many times.
- Confidential Issue
Customers or suppliers, unable or unwilling, for the protection of trade secrets reason, to provide ingredient, function, use, composition and other details of the biopharmaceutical products.
- The heel of achilles
An authorization must be obtained before Import/Export your biopharmaceutical products like reagent, protein and accompany intermediate. A license must to be gained before every shipment. Some Import/Export authorization is unable to obtain due to CRO company's business scope limited.
Top 5 reasons to attend
You can learn the latest trends in CIQ policy for CRO industry!
It’s a great opportunity to network with layer, consultant & more!
To know how to speed up the customs process, save time and cost!
Familiar with the legal clause, prevent the Pre-classification risks!
Familiar with the tax issue about tariff and VAT!